References
- Hakama M, Joutsenlahti U, Virtanen A, Rasanen-Virtanen U. Mass screenings for cervical cancer in Finland 1963–71. Organization, extent, and epidemiological implications. Ann Clin Res 1975;7:101–11.
- Clemmesen J. Statistical studies in the aetiology of malignant neoplasms. I. Review and results. I. Acta Pathol Microbiol Scand Suppl 1965;174:1–543.
- Clemmesen J. Statistical studies in the aetiology of malignant neoplasms. II. Basic tables, Denmark 1943–57. II. Acta Pathol Microbiol Scand Suppl 1965;174:1–319.
- Hakama M, Pukkala E, Saastamoinen P. Selective screening: Theory and practice based on high-risk groups of cervical cancer. J Epidemiol Community Health 1979;33:257–61.
- Hakama M, Pukkala E. Selective screening for cervical cancer. Experience of the Finnish mass screening system. Br J Prev Soc Med 1977;31:238–44.
- Viikki M, Pukkala E, Hakama M. Bleeding symptoms and subsequent risk of gynecological and other cancers. Acta Obstet Gynecol Scand 1998;77:564–9.
- Viikki M, Pukkala E, Hakama M. Risk of cervical cancer subsequent to a positive screening cytology: Follow-up study in Finland. Acta Obstet Gynecol Scand 2000;79:576–9.
- Teppo L, Pukkala E, Lehtonen M. Data quality and quality control of a population-based cancer registry. Experience in Finland. Acta Oncol 1994;33:365–9.
- Melnikow J, Nuovo J, Willan AR, Chan BK, Howell LP. Natural history of cervical squamous intraepithelial lesions: A meta-analysis. Obst Gynecol 1998;92:727–35.
- Wright TC, Jr., Cox JT, Massad LS, Twiggs LB, Wilkinson EJ. 2001 Consensus guidelines for the management of women with cervical cytological abnormalities. JAMA 2002;287:2120–9.
- International Agency for Research on Cancer. IARC Handbooks of Cancer Prevention Volume 10: Cervix Cancer Screening. Lyon: IARC Press; 2005.
- Nieminen P, Kallio M, Anttila A, Hakama M. Organised vs. spontaneous Pap-smear screening for cervical cancer: A casecontrol study. Int J Cancer 1999;83:55–8.